The maverick entrepreneur, known for embellishing the facts, provided no conclusive evidence as to the veracity of his claim.
The era of bioelectronic healthcare is dawning upon us. As electronic systems shrink in size and improve in functionality, we see more and more emerging devices that can track vital signs, such as heart rate and blood pressure, realising the grand vision of highly connected sensor nodes monitoring patients’ health beyond the hospital doors. The real revolution in digital healthcare, however, lies in bringing not only the diagnostics but also the therapy to the patient which requires interfacing the world of electronics with biology.
Interfacing the nervous system provides an immense opportunity to observe (through recording) and modify (through stimulation) the functional state of the biological system to fundamentally understand various diseases and health conditions, and to ultimately develop suitable therapies through closed-loop systems [1]. Consequently, a host of neural interface modalities, with varying levels of invasiveness, have been developed over the past decades. Among all, interfacing at the individual neuron level allows the highest level of information transfer from the brain.
Despite the success of devices such as Cochlear Implants, interfacing at the individual neuron level is still severely limited due to challenges such as selectivity (for stimulation) and thermal-limitations imposed on data transmission to prevent neural tissue damage. The latter is a major bottleneck in improving information transfer rate of neural recording systems as they scale up. Hence, there is currently a tremendous drive to develop new enabling technologies for neuroscience to provide insightful views on how motor or sensory information is represented and transformed by the brain, as well as revealing how this complex system is affected by neurological injuries and disease.
USA: A cross-sectional study comprising 2,822 US adults revealed that worse examination-based and self-reported vision impairment is associated with anxiety and depressive symptoms, and worse examination-based vision impairment is linked with severe social isolation.
These findings, published in JAMA Ophthalmology, provide evidence to support prioritizing research aimed at enhancing the health and inclusion of people with vision impairment.
Vision impairment and psychosocial function, including symptoms of anxiety, depression and social isolation, are a major cause of morbidity in the US. However, there is a lack of nationally representative studies evaluating associations between subjective and objective vision impairment with psychosocial function following the COVID-19 pandemic.
Blood–brain barrier: A physical and biochemical boundary between the bloodstream and the parenchyma of the central nervous system (CNS).
Editorial from The New England Journal of Medicine — Sounding Out the Blood–Brain Barrier.
Experiment records minuscule gravitational pull as a step to understanding how force operates at subatomic level.
Experts from Michigan Medicine answer questions about brain health and how to prevent Alzheimer’s disease.
Learn more about the Michigan Alzheimer’s Disease Center at University of Michigan Health: https://alzheimers.med.umich.edu/
Continue reading “What You Can Do Now to Prevent Alzheimer’s Disease” »
Musk said that the first human patient implanted with a Neuralink chip last month “is able to… move the mouse around the screen just by thinking.”
Elon Musk announced this week that his company’s brain implant has allowed a person to move a computer mouse with their mind.
Neuralink’s first human patient able to use mouse…:
Elon Musk is the visionary behind Neuralink. He announced that the first human recipient of the company’s brain chip implant has fully recovered. The individual has demonstrated the ability to use a computer mouse solely through thoughts. Watch this video for all details.
Researchers have unraveled how mutations in a gene can lead to an incurable neurodevelopmental disorder that causes abnormal brain development in newborns and infants.
The WEHI study is the first to prove that a protein called Trabid helps control neuronal development, and that mutations to this protein can lead to microcephaly —a condition where a baby’s brain is smaller than expected.
It’s hoped the milestone findings will provide a deeper understanding into the protein’s impact on healthy development and lead to treatments that can slow or stop the development of microcephaly and potentially other neurological disorders.
